Asian Pharmaceuticals Private LTD.

Name

Asian Pharmaceuticals Private LTD.

Legal name

Asian Pharmaceuticals Pvt. Ltd.

Website

https://asianpharmaceuticals.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

101–250 employees

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industries

Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ), Pulmonology & Allergy Specialty Pharmaceuticals (HLAIACAF)

Keywords

• Pharmaceutical manufacturing
• Generic medicines
• Prescription drugs
• Veterinary pharmaceuticals
• Neuropsychiatric medications

Headquarters

HQ city

Kathmandu

HQ country

Nepal

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain

Revenue model

1. Pharmaceutical Product Sales: Asian Pharmaceuticals manufactures and sells prescription and non-prescription drugs across Nepal. The company operates multiple divisions (Pharma, Solar I, Solar II, Animal Care, Naisa, Kardib) offering over 240 different medicines. Products are sold through a professional marketing team and distributed via stockists and distributors.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

Asian Pharmaceuticals is a Nepal-based pharmaceutical manufacturer that develops, formulates, produces, and markets over 240 prescription and non-prescription medicines through seven therapeutic divisions (Pharma, Solar I, Solar II, Animal Care, Naisa, and KARDIB). The company manufactures solid, semi-solid, liquid oral, and external-use dosage forms in tablets, capsules, dry syrups, oral liquids, gels, mouthwashes, and water-soluble powders, and sells through stockists, distributors, and a professional marketing team across Nepal.

Product overview

Asian Pharmaceuticals Private Limited (ASP) is one of Nepal's premier manufacturers of prescription and non-prescription drugs, producing over 240 different medicines. The company operates multiple product divisions: the main Pharma Division (producing gastrointestinal, orthopedic, anti-allergic drugs and vitamins including 47 products); Solar I and Solar II Neuropsychiatric Divisions (52 and 60 products respectively covering antidepressants, antipsychotics, anxiolytics, nootropics); Animal Care Division (52 veterinary products); Naisa Division (50 products for market penetration); and KARDIB Cardio Diabetic Division (30+ launched products, 50 in development). The product portfolio includes solid, semi-solid, liquid oral, and external use solutions. Manufacturing facility is WHO-GMP and ISO certified with separate production areas for pharma and veterinary products.

Differentiator

Problem solved

Functional benefit

Brands

• Solar I Division: Neuropsychiatric division launched in 2056 BS (2000 AD) with 52 products covering antibiotics, antihypertensive, antipsychotic, and NSAID categories.
• Solar II Division
• Pharma Division
• Animal Care Division
• Naisa Division
• KARDIB Division

Products and services

• Pharma Division The primary pharmaceutical division of Asian Pharmaceuticals, manufacturing and marketing 47 products including gastrointestinal drugs (acid secretion inhibitors such as Pantop), ortho products (uric acid related, pain killers, anti-inflammatory drugs such as NIMS), anti-allergic medications, and vitamins for the Nepal market.
• Solar I Division The first independent Neuropsychiatric Division in Nepal, offering 52 neuropsychiatric products covering antibiotics, antihypertensive, antipsychotic, and NSAID categories for patients with mental health and neurological conditions.
• Solar II Division Neuropsychiatric product division with 60 products covering anti-depressants, anxiolytics, antipsychotics, nootropics, antimanics, and antiparkinsonian medications for better market outreach within Nepal.
• Animal Care Division Veterinary pharmaceutical division of Asian Pharmaceuticals, with a dedicated manufacturing plant producing 52 products including antibiotics and antimicrobials, multivitamins, and minerals for veterinary animals in Nepal.
• Naisa Division Pharmaceutical division with 50 products spanning gastrointestinal drugs (acid secretion inhibitors), antibiotics, ortho products (uric acid related, pain killers, anti-inflammatory), asthma treatments, antiallergic, gynecological, and dental products, aimed at improved market penetration in Nepal.
• KARDIB Division (Cardio Diabetic Division) The cardio diabetic division of Asian Pharmaceuticals, with over 30 products launched initially and over 50 in the R&D phase, covering antihypertensive drugs (calcium channel blockers, angiotensin blockers, diuretics), antiplatelets, hypolipidaemic drugs, and oral hypoglycaemic drugs for Nepalese patients with cardiovascular conditions and diabetes.
• THIOSIDE (Thiocolchicoside Capsules IP) Muscle relaxant capsules containing Thiocolchicoside IP 4 mg per capsule, indicated as adjuvant treatment of painful muscle contractures in acute spinal pathology in adults and adolescents aged 16 years and older.
• PULMOFIB (Pirfenidone) Anti-inflammatory, antioxidant, and anti-fibrotic film-coated tablets containing Pirfenidone 200mg and 400mg, indicated for treatment of idiopathic pulmonary fibrosis (IPF), improving lung function and reducing acute exacerbations.
• PRESITON (Spironolactone) Potassium-sparing diuretic and antihypertensive tablets containing Spironolactone in 25mg, 50mg, and 100mg strengths, indicated for primary hyperaldosteronism, edematous conditions, essential hypertension, hypokalemia, and severe heart failure.
• VPRAZ (Vonoprazan Fumarate) Potassium-competitive acid blocker (PCAB) film-coated tablets containing Vonoprazan Fumarate in 10mg and 20mg strengths, used for gastric ulcer, duodenal ulcer, reflux esophagitis, and as adjunct to Helicobacter pylori eradication.
• PRESIN (Amlodipine Besylate) Calcium channel blocker film-coated tablets containing Amlodipine Besylate in 2.5mg, 5mg, and 10mg strengths, used alone or in combination for hypertension and coronary artery disease, including chronic stable angina and vasospastic angina.
• VALPROT (Sodium Valproate Oral Solution) Antiepileptic oral solution containing Sodium Valproate IP 200mg per 5mL, used for treatment of generalized, partial or other epilepsy and in treatment of mania.
• PANTOP-S (S-Pantoprazole) Proton pump inhibitor (PPI) enteric-coated tablet containing S-Pantoprazole 20mg, indicated for treatment of duodenal ulcer, gastric ulcer, gastroesophageal reflux disease (GERD), and pathological hypersecretory conditions.
• TRICHEK (Fenofibrate) Fibric acid derivative lipid-lowering agent available in 160mg tablets and 200mg capsules, used as adjunctive therapy to diet for reducing elevated LDL-C, Total-C, triglycerides, and increasing HDL-C in patients with hyperlipidemia.
• MINTGARD MPS (Antacid Suspension) Antacid suspension with Oxetacaine and Simethicone, containing Dried Aluminium Hydroxide Gel, Magnesium Hydroxide, Simethicone, and Oxetacaine, used to relieve symptoms of gastric and duodenal ulcers, gastritis, heartburn, and indigestion.
• MFT XR (Metformin Hydrochloride Extended-Release) Antihyperglycemic extended-release tablet containing Metformin Hydrochloride in 500mg, 850mg, and 1000mg strengths, used as adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
• LIPOSTAT (Atorvastatin) HMG-CoA reductase inhibitor film-coated tablets containing Atorvastatin in 10mg and 20mg strengths, used for prevention of cardiovascular events and lowering LDL cholesterol levels in patients with hyperlipidemia.
• LINAGLIP-M (Linagliptin + Metformin) Combination DPP-4 inhibitor and biguanide tablets containing 2.5mg Linagliptin with 500mg, 850mg, or 1000mg Metformin, used as adjunct to diet and exercise for glycemic control in type 2 diabetes.
• EMPERA (Empagliflozin) SGLT2 inhibitor film-coated tablets containing Empagliflozin in 10mg and 25mg strengths, used for treatment of type 2 diabetes mellitus and symptomatic chronic heart failure in adults.
• DIUMIDE-S (Furosemide + Spironolactone) Combination diuretic tablets containing Furosemide IP 20mg and Spironolactone IP 50mg, used for resistant edema associated with secondary hyperaldosteronism such as in chronic heart failure and hepatic cirrhosis.
• DIUMIDE (Furosemide) Loop diuretic tablets containing Furosemide in 20mg and 40mg strengths, used for treatment of edema associated with congestive heart failure, cirrhosis of the liver, renal disease, and hypertension.

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature3 records

Partnerships

Six partnerships are on record, tiered core, moderate and minor.

• Association of Pharmaceutical Producers of Nepal (APPON)coreOthers · 1 September 2015Shanker Ghimire, Executive Director of Asian Pharmaceuticals, serves as President of APPON since September 2015. APPON is the representative body of Nepali pharmaceutical companies, lobbying on industry-related issues and working for healthy growth of the sector.
• FNCCI (Federation of Nepalese Chambers of Commerce and Industry)moderateStrategic or Co-development PartnerAsian Pharmaceuticals participated in earthquake relief program organized by FNCCI during the April 2015 earthquake, distributing medical emergency materials for nearly a month along with manufacturing and marketing staff.
• AMA FoundationminorOthersAMA Foundation is one of the organizations supported by Asian Pharmaceuticals through social responsibility activities.
• Rotary ClubminorOthersRotary Club is mentioned as one of the organizations in Asian Pharmaceuticals' social responsibility network.
• TEWAminorOthersTEWA (Women for Human Rights) is one of the organizations supported by Asian Pharmaceuticals to uplift women and children.
• AAMA GHARminorOthersAAMA GHAR is one of the organizations supported by Asian Pharmaceuticals working to uplift women and children.

Scale indicators6 records

Recent moves9 records

Expansion highlights5 records

Broad incumbents

• Cipla: Indian multinational pharmaceutical company and one of the largest suppliers of generics to Nepal. Comparable as the dominant foreign competitor whose products make up the majority of Nepal's pharmaceutical market; competes with Asian Pharmaceuticals across most therapeutic categories.
• Mankind Pharma: Large Indian generic manufacturer with strong presence across South Asian markets including Nepal. Comparable as a high-volume, cost-competitive generic supplier whose products compete directly with Asian Pharmaceuticals' portfolio in Nepal's price-sensitive market.
• Torrent Pharmaceuticals: Indian multinational with strong cardiology and chronic-disease portfolio, the same categories where Asian Pharmaceuticals' KARDIB division competes. Relevant as a foreign competitor whose branded generics vie for the same prescription slots in Nepal.
• Sun Pharmaceutical Industries: India's largest pharmaceutical company with extensive generic portfolio including cardiology, psychiatry, and gastroenterology. Relevant as a primary foreign competitor in Nepal and a benchmark for the scale Asian Pharmaceuticals would need to reach for international expansion.

Direct peers

• National Healthcare Pvt. Ltd. Nepal-based pharmaceutical manufacturer with a multi-division structure covering general medicine and specialty categories. Comparable to Asian Pharmaceuticals in market positioning as a mid-sized domestic player serving the Nepalese population.
• Time Pharmaceuticals: Nepal-based generic pharmaceutical manufacturer with multiple therapeutic divisions and WHO-GMP certification. Directly comparable to Asian Pharmaceuticals in product count, Nepal domestic market focus, and professional field-force-driven distribution.
• Deurali-Janta Pharmaceuticals: Nepali pharmaceutical company producing prescription and OTC generics for domestic distribution. Comparable to Asian Pharmaceuticals in scale, regulatory certifications, and broad therapeutic portfolio targeting Nepalese healthcare providers.
• Nepal Pharmaceuticals Lab: Established Nepali pharmaceutical manufacturer with a broad generic portfolio across human and veterinary segments. Comparable to Asian Pharmaceuticals in target market (Nepal), manufacturing scale, and multi-division structure serving primary care and chronic disease categories.
• Lomus Pharmaceuticals: One of Nepal's largest domestic pharmaceutical manufacturers producing branded generics across multiple therapeutic categories. Directly comparable to Asian Pharmaceuticals in product breadth, Nepal-only distribution model, and WHO-GMP-certified manufacturing scale.

Emerging players

• Swiss Garnier Life Sciences: Nepali pharmaceutical manufacturer with growing product portfolio across multiple therapeutic areas. Comparable to Asian Pharmaceuticals as a domestic Nepali manufacturer targeting similar customer segments, though smaller in scale and product breadth.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/asian-pharmaceuticals

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Asian Pharmaceuticals Private LTD.